If you made any changes in Pure these will be visible here soon.

Personal profile


Associate Professor Dear completed his medical degree, with honours, at Monash University. He continued his clinical training at the Alfred and Box Hill Hospital campuses and currently holds an appointment at Eastern Health as a clinical consultant in Vascular Medicine. Associate Professor Dear obtained his PhD from Monash University for research examining the molecular biological control of components of the plasminogen activating system.

Associate Professor Dear heads the Eastern Clinical Research Unit (ECRU) Translational Research Division Laboratory at Monash University, Department of Medicine, Eastern Health Clinical School.

Associate Professor Dear is involved in numerous scientific collaborations with national and international research groups focusing on translational research programmes in several clinical disciplines.

See more detail of Anthony's research and team at:


Research interests

The ECRU Translational Research Division laboratory is based at the Eastern Health Clinical School, Monash University Department of Medicine. Within the laboratory I supervise a research team involved in in vitro and in vivo evaluation of novel HDACi's and a number of other translational research projects. The research team consists of Dr Hong Bin Liu (Post Doctoral Research Fellow), Dr Yushan Hu (Post Doctoral Research Fellow), past and present BSc (Hons) and PhD students. The laboratory is funded through competitive granting agencies together with pharmaceutical company research grants.

Research area keywords

  • Cancer Biology
  • Cellular Biology
  • Clinical Trial
  • Demethylation Agents
  • Diabetes
  • Epigenetics
  • Glucagon-Like
  • Endothelial Cells
  • Histone Deacetylase Inhibitors
  • Molecular Biology
  • Translational Research
  • Vascular Biology
  • Vascular Disease

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2018

Research Output 1994 2018

Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis

Gaspari, T., Spizzo, I., Liu, H., Hu, Y., Simpson, R. W., Widdop, R. E. & Dear, A. E., 1 Jan 2018, In : Diabetes and Vascular Disease Research. 15, 1, p. 64-73 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Association between metformin prescription and growth rates of abdominal aortic aneurysms

Golledge, J., Moxon, J. V., Pinchbeck, J., Anderson, G., Rowbotham, S., Jenkins, J., Bourke, M., Bourke, B., Dear, A., Buckenham, T., Jones, R. & Norman, P. E., Oct 2017, In : British Journal of Surgery. 104, 11, p. 1486-1493 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Current and emerging pharmacotherapies for obesity in Australia

Hocking, S., Dear, A. & Cowley, M. A., 1 Sep 2017, In : Obesity Research and Clinical Practice. 11, 5, p. 501-521 21 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

Epigenetic Modulators and the New Immunotherapies

Dear, A. E., 18 Feb 2016, In : New England Journal of Medicine. 374, 7, p. 684-686 3 p.

Research output: Contribution to journalArticleOtherpeer-review

Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies

Liu, H. B., Pattie, P., Chandrasekara, S., Spencer, A. & Dear, A. E., Sep 2016, In : Oncology Letters. 12, 3, p. 2175-2180 6 p.

Research output: Contribution to journalArticleResearchpeer-review